Psagot Value Holdings Ltd. - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
Psagot Value Holdings Ltd. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$8,000
-27.3%
6,0000.0%0.00%
Q2 2021$11,000
-99.9%
6,000
-99.8%
0.00%
-100.0%
Q1 2021$13,807,000
+708.8%
3,095,741
+558.3%
0.31%
+675.0%
Q4 2020$1,707,000
-6.2%
470,2550.0%0.04%
-13.0%
Q3 2020$1,820,000
+5.2%
470,2550.0%0.05%
-4.2%
Q2 2020$1,730,000
+81.2%
470,255
+15.7%
0.05%
+23.1%
Q1 2020$955,000406,355
+406255.0%
0.04%
Q4 2019$01000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Spire Wealth Management 148,800$158,0000.00%
MEITAV INVESTMENT HOUSE LTD 244,332$257,0000.00%
Phoenix Holdings Ltd. 244,113$259,0000.00%
IHT Wealth Management, LLC 24,000$25,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Virtu Financial LLC 15,199$16,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 41,574$44,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,790$31,0000.00%
BANK OF AMERICA CORP /DE/ 5,153$5,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders